As of 2025-03-21, the Relative Valuation of Erytech Pharma SA (ERYP.PA) is 0.14 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 EUR, the upside of Erytech Pharma SA based on Relative Valuation is -71.9%.
The range of the Relative Valuation is (0.08) - 0.45 EUR.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 23.0x | 10.0x |
| Forward P/E multiples | 21.1x - 38.7x | 31.7x |
| Fair Price | (0.08) - 0.45 | 0.14 |
| Upside | -115.9% - -10.7% | -71.9% |
| Date | P/E |